CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

被引:173
作者
Escamilla, Jemima [1 ]
Schokrpur, Shiruyeh [1 ]
Liu, Connie [1 ]
Priceman, Saul J. [2 ]
Moughon, Diana [1 ]
Jiang, Ziyue [1 ,3 ]
Pouliot, Frederic [4 ]
Magyar, Clara [5 ]
Sung, James L. [1 ]
Xu, Jingying [1 ]
Deng, Gang [6 ]
West, Brian L. [7 ]
Bollag, Gideon [7 ]
Fradet, Yves [4 ]
Lacombe, Louis [4 ]
Jung, Michael E. [6 ]
Huang, Jiaoti [5 ]
Wu, Lily [1 ,3 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Beckman Res Inst City Hope, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[4] CHU Quebec, Div Urol, Dept Surg, Quebec City, PQ, Canada
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA
[7] Plexxikon Inc, Berkeley, CA USA
关键词
TUMOR-ASSOCIATED MACROPHAGES; STIMULATING FACTOR-1 RECEPTOR; INFILTRATING MYELOID CELLS; TYROSINE KINASE INHIBITOR; IN-VIVO; CASTRATION; PROGRESSION; METASTASIS; INFLAMMATION; MECHANISMS;
D O I
10.1158/0008-5472.CAN-14-0992
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Growing evidence suggests that tumor-associated macrophages (TAM) promote cancer progression and therapeutic resistance by enhancing angiogenesis, matrix-remodeling, and immunosuppression. In this study, prostate cancer under androgen blockade therapy (ABT) was investigated, demonstrating that TAMs contribute to prostate cancer disease recurrence through paracrine signaling processes. ABT induced the tumor cells to express macrophage colony-stimulating factor 1 (M-CSF1 or CSF1) and other cytokines that recruit and modulate macrophages, causing a significant increase in TAM infiltration. Inhibitors of CSF1 signaling through its receptor, CSF1R, were tested in combination with ABT, demonstrating that blockade of TAM influx in this setting disrupts tumor promotion and sustains a more durable therapeutic response compared with ABT alone. (C)2015 AACR.
引用
收藏
页码:950 / 962
页数:13
相关论文
共 49 条
[1]
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer [J].
Ammirante, Massimo ;
Luo, Jun-Li ;
Grivennikov, Sergei ;
Nedospasov, Sergei ;
Karin, Michael .
NATURE, 2010, 464 (7286) :302-U187
[2]
Pharmacodynamic activity demonstrated in phase I for PLX3397, a selective inhibitor of FMS and Kit. [J].
Anthony, S. P. ;
Puzanov, I. ;
Lin, P. S. ;
Nolop, K. B. ;
West, B. ;
Von Hoff, D. D. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[3]
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway [J].
Attard, Gerhardt ;
Richards, Juliet ;
de Bono, Johann S. .
CLINICAL CANCER RESEARCH, 2011, 17 (07) :1649-1657
[4]
Modulating metastasis by a lymphangiogenic switch in prostate cancer [J].
Brakenhielm, Ebba ;
Burton, Jeremy B. ;
Johnson, Mai ;
Chavarria, Nelson ;
Morizono, Kouki ;
Chen, Irvin ;
Alitalo, Kari ;
Wu, Lily .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (10) :2153-2161
[5]
Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis [J].
Burton, Jeremy B. ;
Priceman, Saul J. ;
Sung, James L. ;
Brakenhielm, Ebba ;
An, Dong Sung ;
Pytowski, Bronislaw ;
Alitalo, Kari ;
Wu, Lily .
CANCER RESEARCH, 2008, 68 (19) :7828-7837
[6]
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway [J].
Chen, Hongbing ;
Sun, Yin ;
Wu, Chengyu ;
Magyar, Clara E. ;
Li, Xinmin ;
Cheng, Liang ;
Yao, Jorge L. ;
Shen, Steven ;
Osunkoya, Adeboye O. ;
Liang, Chaozhao ;
Huang, Jiaoti .
ENDOCRINE-RELATED CANCER, 2012, 19 (03) :321-331
[7]
Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[8]
Macrophage Regulation of Tumor Responses to Anticancer Therapies [J].
De Palma, Michele ;
Lewis, Claire E. .
CANCER CELL, 2013, 23 (03) :277-286
[9]
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy [J].
DeNardo, David G. ;
Brennan, Donal J. ;
Rexhepaj, Elton ;
Ruffell, Brian ;
Shiao, Stephen L. ;
Madden, Stephen F. ;
Gallagher, William M. ;
Wadhwani, Nikhil ;
Keil, Scott D. ;
Junaid, Sharfaa A. ;
Rugo, Hope S. ;
Hwang, E. Shelley ;
Jirstroem, Karin ;
West, Brian L. ;
Coussens, Lisa M. .
CANCER DISCOVERY, 2011, 1 (01) :54-67
[10]
The changing landscape in the treatment of metastatic castration-resistant prostate cancer [J].
El-Amm, Joelle ;
Aragon-Ching, Jeanny B. .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (01) :25-40